Kiyomi O. Toyooka
Papers
1
Total Citations
33
H-Index
1
About
Dr. Kiyomi O. Toyooka is a pioneering molecular biologist whose work has fundamentally advanced the understanding of epigenetic mechanisms in cancer, particularly through the lens of DNA methylation. Her research focuses on the role of promoter methylation in silencing tumor suppressor genes, with a special emphasis on CDH1, a critical gene for cell adhesion whose loss drives metastasis. Her most cited work, "Establishment and Validation of Real-Time Polymerase Chain Reaction Method for CDH1 Promoter Methylation" (2002, 33 citations), provided a robust, quantitative framework for detecting epigenetic alterations in clinical samples. This methodological breakthrough enabled more precise and reproducible analysis of methylation patterns, directly impacting how researchers and clinicians identify biomarkers for early cancer detection and prognosis. Dr. Toyooka’s contributions have been instrumental in bridging basic epigenetic science with translational applications, offering tools that enhance the accuracy of molecular diagnostics. Her legacy lies in empowering the scientific community to explore how reversible epigenetic changes can be targeted for therapeutic intervention, making her a key figure in the ongoing effort to demystify cancer’s epigenetic landscape.
Research Focus
Key Achievements
Top Papers
- 1